SciSparc Ltd. (SPRC)
SPRC Stock Price Chart
Explore SciSparc Ltd. interactive price chart. Choose custom timeframes to analyze SPRC price movements and trends.
SPRC Company Profile
Discover essential business fundamentals and corporate details for SciSparc Ltd. (SPRC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Aug 2021
Employees
2.00
Website
https://scisparc.comCEO
Oz Adler CPA
Description
SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in soft gel capsule form. It also has an agreement with the Sheba Fund for Health Services and Research to examine the potential role of SCI-210 for the treatment of status epilepticus; and The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.
SPRC Financial Timeline
Browse a chronological timeline of SciSparc Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 24 Jul 2025
Stock split effective on 3 Jul 2025
Shares were split 1 : 21 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 24 Apr 2025
EPS came in at -$1.40 , while revenue for the quarter reached $466.00K .
Earnings released on 1 Jul 2024
EPS came in at -$1.70 , while revenue for the quarter reached $840.00K .
Earnings released on 6 May 2024
EPS came in at -$0.81 , while revenue for the quarter reached $907.00K .
Stock split effective on 28 Sept 2023
Shares were split 1 : 26 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 7 Aug 2023
EPS came in at -$2.17 , while revenue for the quarter reached $1.97M .
Earnings released on 27 Apr 2023
EPS came in at $2.77 , while revenue for the quarter reached $1.35M .
Earnings released on 28 Jul 2022
EPS came in at -$4.68 .
Earnings released on 4 Apr 2022
EPS came in at -$3.47 , while revenue for the quarter reached $1.07M .
Earnings released on 26 Aug 2021
EPS came in at -$3.95 .
SPRC Stock Performance
Access detailed SPRC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.